Cargando…

PERSISTENCE OF PLASMODIUM FALCIPARUM HRP2 ANTIGEN AFTER EFFECTIVE ANTIMALARIAL THERAPY

INTRODUCTION: Histidine Rich Protein 2 based (HRP2-based) malaria rapid diagnostic tests (mRDTs) have been shown to perform as well as routine light microscopy, however, they are limited by some factors including persistence of HRP2 antigenemia. In this paper we report the evaluation of an HRP2-base...

Descripción completa

Detalles Bibliográficos
Autores principales:	Michael, O.S., Orimadegun, A.E., Falade, C.O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Association of Resident Doctors (ARD), University College Hospital, Ibadan 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935674/ https://www.ncbi.nlm.nih.gov/pubmed/35330886

Ejemplares similares

Persistence of Plasmodium falciparum HRP-2 antigenaemia after artemisinin combination therapy is not associated with gametocytes
por: Oulton, Tate, et al.
Publicado: (2022)

HRP2 and HRP3 cross-reactivity and implications for HRP2-based RDT use in regions with Plasmodium falciparum hrp2 gene deletions
por: Kong, Amy, et al.
Publicado: (2021)

Operational accuracy and comparative persistent antigenicity of HRP2 rapid diagnostic tests for Plasmodium falciparum malaria in a hyperendemic region of Uganda
por: Kyabayinze, Daniel J, et al.
Publicado: (2008)

Comparison of the susceptibility of Plasmodium knowlesi and Plasmodium falciparum to antimalarial agents
por: van Schalkwyk, Donelly A, et al.
Publicado: (2017)

Modelling the epidemiology of malaria and spread of HRP2-negative Plasmodium falciparum following the replacement of HRP2-detecting rapid diagnostic tests
por: Chaudhry, Alisha, et al.
Publicado: (2022)

High-throughput Plasmodium falciparum hrp2 and hrp3 gene deletion typing by digital PCR to monitor malaria rapid diagnostic test efficacy
por: Vera-Arias, Claudia A, et al.
Publicado: (2022)

The in-vivo dynamics of Plasmodium falciparum HRP2: implications for the use of rapid diagnostic tests in malaria elimination
por: Marquart, Louise, et al.
Publicado: (2022)

Plasmodium falciparum histidine-rich protein (PfHRP2 and 3) diversity in Western and Coastal Kenya
por: Nderu, David, et al.
Publicado: (2019)

Antimalarials increase vesicle pH in Plasmodium falciparum
Publicado: (1985)

Validation of Plasmodium falciparum deoxyhypusine synthase as an antimalarial target
por: Aroonsri, Aiyada, et al.
Publicado: (2019)

Extrachromosomal DNA amplicons in antimalarial‐resistant Plasmodium falciparum
por: McDaniels, Jennifer M., et al.
Publicado: (2020)

Plasmodium falciparum Nicotinamidase as A Novel Antimalarial Target
por: Donu, Dickson, et al.
Publicado: (2022)

Serum Apolipoprotein-A1 and Cholesterol Levels in Nigerian Children with Plasmodium falciparum Infection
por: Orimadegun, Adebola Emmanuel, et al.
Publicado: (2015)

Robenidine Analogues Are Potent Antimalarials in Drug-Resistant Plasmodium falciparum
por: Krollenbrock, Alina, et al.
Publicado: (2021)

Portable and cost-effective genetic detection and characterization of Plasmodium falciparum hrp2 using the MinION sequencer
por: Sabin, Susanna, et al.
Publicado: (2023)

Modelling the drivers of the spread of Plasmodium falciparum hrp2 gene deletions in sub-Saharan Africa
por: Watson, Oliver J, et al.
Publicado: (2017)

Plasmodium falciparum HRP2 ELISA for analysis of dried blood spot samples in rural Zambia
por: Gibson, Lauren E., et al.
Publicado: (2017)

High prevalence and extended deletions in Plasmodium falciparum hrp2/3 genomic loci in Ethiopia
por: Golassa, Lemu, et al.
Publicado: (2020)

Genetic diversity of Plasmodium falciparum histidine-rich protein 2 (PfHRP2) and its effect on the performance of PfHRP2-based rapid diagnostic tests
por: Mussa, Ali, et al.
Publicado: (2019)

Associations between Antibodies to a Panel of Plasmodium falciparum Specific Antigens and Response to Sub-Optimal Antimalarial Therapy in Kampala, Uganda
por: Keh, Chris E., et al.
Publicado: (2012)

Sensitivity of Plasmodium falciparum to Antimalarial Drugs in Hainan Island, China
por: Wang, Shan-Qing, et al.
Publicado: (2015)

The impact of antimalarial resistance on the genetic structure of Plasmodium falciparum in the DRC
por: Verity, Robert, et al.
Publicado: (2020)

Susceptibility of Ugandan Plasmodium falciparum Isolates to the Antimalarial Drug Pipeline
por: Kreutzfeld, Oriana, et al.
Publicado: (2023)

Chemogenomic profiling of Plasmodium falciparum as a tool to aid antimalarial drug discovery
por: Pradhan, Anupam, et al.
Publicado: (2015)

Performance of an ultra-sensitive Plasmodium falciparum HRP2-based rapid diagnostic test with recombinant HRP2, culture parasites, and archived whole blood samples
por: Das, Smita, et al.
Publicado: (2018)

Targeting the Plasmodium falciparum proteome and organelles for potential antimalarial drug candidates
por: Abugri, James, et al.
Publicado: (2022)

Persistence of chloroquine-resistant haplotypes of Plasmodium falciparum in children with uncomplicated Malaria in Lagos, Nigeria, four years after change of chloroquine as first-line antimalarial medicine
por: Oladipo, Oladosu O, et al.
Publicado: (2015)

Isoxazolopyrimidine-Based Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase with Antimalarial Activity
por: Kokkonda, Sreekanth, et al.
Publicado: (2018)

Continued cytoadherence of Plasmodium falciparum infected red blood cells after antimalarial treatment
por: Hughes, Katie R., et al.
Publicado: (2010)

Correction to: Performance of an ultra-sensitive Plasmodium falciparum HRP2-based rapid diagnostic test with recombinant HRP2, culture parasites, and archived whole blood samples
por: Das, Smita, et al.
Publicado: (2019)

Targeting Plasmodium falciparum Hsp90: Towards Reversing Antimalarial Resistance
por: Shahinas, Dea, et al.
Publicado: (2013)

Genomic Epidemiology of Antimalarial Drug Resistance in Plasmodium falciparum in Southern China
por: Huang, Fang, et al.
Publicado: (2021)

Performance of pfHRP2 versus pLDH antigen rapid diagnostic tests for the detection of Plasmodium falciparum: a systematic review and meta-analysis
por: Li, Bo, et al.
Publicado: (2017)

Secretion of a malarial histidine-rich protein (Pf HRP II) from Plasmodium falciparum-infected erythrocytes
Publicado: (1986)

SD Bioline malaria antigen Pf (HRP-2/pLHD) for assessing efficacy of artemisinin combination therapy against Plasmodium falciparum in pediatric patients in the Democratic Republic of the Congo
por: Kilauzi, Albert Lukuka, et al.
Publicado: (2015)

PERSPECTIVE: SUSTAINING EFFECTIVE MALARIA CONTROL DURING THE COVID-19 PANDEMIC
por: Michael, O.S., et al.
Publicado: (2021)

Plasmodium falciparum merozoite invasion ligands, linked antimalarial resistance loci and ex vivo responses to antimalarials in The Gambia
por: Mbye, Haddijatou, et al.
Publicado: (2022)

In vitro analyses of Artemisia extracts on Plasmodium falciparum suggest a complex antimalarial effect
por: Gruessner, Brian M., et al.
Publicado: (2021)

Pyrazoleamide compounds are potent antimalarials that target Na(+) homeostasis in intraerythrocytic Plasmodium falciparum
por: Vaidya, Akhil B., et al.
Publicado: (2014)

How is childhood development of immunity to Plasmodium falciparum enhanced by certain antimalarial interventions?
por: Sutherland, Colin J, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_i5s7tonfghhbpl71s32ss8q9me